Dkk-3 expression in the tumor endothelium: A novel prognostic marker of pancreatic adenocarcinomas

Cancer Science

Volumn 100, Issue 8, 2009, Pages 1414-1420

  Fong, Dominic ^a   Hermann, Martin ^a   Untergasser, Gerold ^a   Pirkebner, Daniela ^a   Draxl, Anna ^a   Heitz, Martin ^a   Moser, Patrizia ^b   Margreiter, Raimund ^a   Hengster, Paul ^a   Amberger, Albert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; DICKKOPF 3 PROTEIN; FLUOROURACIL; GEMCITABINE; PROSTAGLANDIN SYNTHASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CELL GROWTH; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME;

ADENOCARCINOMA; ADENOVIRIDAE; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UMBILICAL VEINS;

EID: 67650666507     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01208.x     Document Type: Article

References (39)

1. Warshaw AL, Fernandez-del CC. Pancreatic carcinoma. N Engl J Med. 1992; 326: 455-65.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66.
3. Klapman J, Malafa MP. Early detection of pancreatic cancer: Why, who, and how to screen. Cancer Control. 2008; 15: 280-7.
4. Berlin JD, Rothenberg ML. Chemotherapeutic advances in pancreatic cancer. Curr Oncol Report. 2003; 5: 219-26.
5. Bodner WR, Hilaris BS, Mastoras DA. Radiation therapy in pancreatic cancer: Current practice and future trends. J Clin Gastroenterol. 2000; 30: 230-3.
6. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002; 29: 15-8.
7. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86: 353-64.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70.
9. St. Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science. 2000; 289: 1197-202.
10. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 2006; 25: 7469-81.
11. Barrantes IB, Montero-Pedrazuela A, Guadano-Ferraz A et al. Generation and characterization of dickkopf3 mutant mice. Mol Cell Biol. 2006; 26: 2317-26.
12. Untergasser G, Steurer M, Zimmermann M et al. The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer. 2008; 122: 1539-47.
13. Hermann M, Pirkebner D, Draxl A et al. Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. Histochem Cell Biol. 2007; 127: 513-21.
14. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997; 80: 1803-4.
15. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JR. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol. 1992; 1: 223-9.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma. N Engl J Med. 1991; 324: 1-8.
17. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma: A quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol. 1986; 22: 1205-9.
18. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993; 143: 401-9.
19. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 1992; 340: 145-6.
20. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology. 1998; 55: 575-81.
21. Lindmark G, Gerdin B, Sundberg C, Pahlman L, Bergstrom R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol. 1996; 14: 461-6.
22. Gasparini G, Weidner N, Bevilacqua P et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol. 1994; 12: 454-66.
23. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer. 1998; 34: 337-40.
24. Karademir S, Sokmen S, Terzi C et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000; 7: 489-95.
25. Takagi K, Takada T, Amano H. A high peripheral microvessel density count correlates with a poor prognosis in pancreatic cancer. J Gastroenterol. 2005; 40: 402-8.
26. Khan AW, Dhillon AP, Hutchins R et al. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol. 2002; 28: 637-44.
27. Ikeda N, Adachi M, Taki T et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer. 1999; 79: 1553-63.
28. Fujioka S, Yoshida K, Yanagisawa S, Kawakami M, Aoki T, Yamazaki Y. Angiogenesis in pancreatic carcinoma: Thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer. 2001; 92: 1788-97.
29. Bittinger F, Klein CL, Skarke C et al. PECAM-1 expression in human mesothelial cells: An in vitro study. Pathobiology. 1996; 64: 320-7.
30. Zitt M, Untergasser G, Amberger A et al. Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: Expression in cancer tissue and adjacent non-cancerous tissue. Dis Markers. 2008; 24: 101-9.
31. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM. Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene. 2006; 25: 6528-37.
32. Kobayashi K, Ouchida M, Tsuji T et al. Reduced expression of the REIC/ Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene. 2002; 282: 151-8.
33. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 2005; 65: 4218-27.
34. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun. 2000; 268: 20-4.
35. Abarzua F, Sakaguchi M, Takaishi M et al. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun -NH2-kinase. Cancer Res. 2005; 65: 9617-22.
36. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002; 62: 5381-5.
37. Burris HA III, Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol. 1997; 15: 2403-13.
38. Crino L, Mosconi AM, Calandri C et al. Gemcitabine in advanced pancreatic cancer: A phase II trial. Am J Clin Oncol. 2001; 24: 296-8.
39. Heinemann V. Gemcitabine: Progress in the treatment of pancreatic cancer. Oncology. 2001; 60: 8-18.